UCN3
Basic information
Region (hg38): 10:5364966-5374692
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UCN3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 23 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 4 | 1 |
Variants in UCN3
This is a list of pathogenic ClinVar variants found in the UCN3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-5373790-C-A | not specified | Uncertain significance (Sep 12, 2023) | ||
10-5373800-A-C | not specified | Uncertain significance (Oct 04, 2024) | ||
10-5373806-C-A | not specified | Uncertain significance (Oct 26, 2021) | ||
10-5373856-G-A | not specified | Likely benign (Jan 20, 2023) | ||
10-5373861-G-C | not specified | Uncertain significance (Nov 11, 2024) | ||
10-5373871-G-A | not specified | Likely benign (Jan 19, 2022) | ||
10-5373874-T-A | not specified | Uncertain significance (Jul 25, 2023) | ||
10-5373893-G-A | not specified | Uncertain significance (Mar 28, 2023) | ||
10-5373919-G-A | not specified | Uncertain significance (Sep 27, 2021) | ||
10-5373926-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
10-5373968-T-A | not specified | Uncertain significance (Aug 05, 2024) | ||
10-5373983-G-A | not specified | Uncertain significance (May 11, 2022) | ||
10-5373998-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
10-5374000-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
10-5374001-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
10-5374042-C-T | not specified | Uncertain significance (Sep 08, 2024) | ||
10-5374052-C-T | not specified | Uncertain significance (May 07, 2024) | ||
10-5374053-G-A | Benign (May 16, 2018) | |||
10-5374057-A-G | not specified | Uncertain significance (Jun 23, 2021) | ||
10-5374085-T-C | not specified | Uncertain significance (Dec 16, 2023) | ||
10-5374092-C-G | Likely benign (May 21, 2018) | |||
10-5374095-C-T | Likely benign (Jun 01, 2018) | |||
10-5374141-A-C | not specified | Uncertain significance (Mar 06, 2023) | ||
10-5374146-C-A | not specified | Uncertain significance (Feb 22, 2023) | ||
10-5374148-T-C | not specified | Uncertain significance (Oct 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UCN3 | protein_coding | protein_coding | ENST00000380433 | 1 | 9198 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0439 | 0.682 | 125732 | 0 | 7 | 125739 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.143 | 103 | 99.0 | 1.04 | 0.00000618 | 1034 |
Missense in Polyphen | 21 | 22.825 | 0.92005 | 188 | ||
Synonymous | -0.0997 | 47 | 46.1 | 1.02 | 0.00000297 | 346 |
Loss of Function | 0.550 | 2 | 3.03 | 0.659 | 1.28e-7 | 43 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000157 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000358 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Suppresses food intake, delays gastric emptying and decreases heat-induced edema. Might represent an endogenous ligand for maintaining homeostasis after stress.;
- Pathway
- Glucocorticoid Pathway (HPA Axis), Pharmacodynamics;Signaling by GPCR;Signal Transduction;Class B/2 (Secretin family receptors);GPCR ligand binding
(Consensus)
Recessive Scores
- pRec
- 0.197
Intolerance Scores
- loftool
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.51
Haploinsufficiency Scores
- pHI
- 0.112
- hipred
- N
- hipred_score
- 0.201
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.362
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ucn3
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; endocrine/exocrine gland phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- adenylate cyclase-activating G protein-coupled receptor signaling pathway;digestion;response to glucose;hormone-mediated signaling pathway;regulation of signaling receptor activity;cellular response to nutrient levels;positive regulation of insulin secretion;response to immobilization stress;response to starvation;positive regulation of membrane potential;response to corticosterone;cellular response to hypoxia
- Cellular component
- extracellular region;extracellular space;varicosity;axon terminus
- Molecular function
- hormone activity;corticotropin-releasing hormone receptor binding;corticotropin-releasing hormone receptor 2 binding